###begin article-title 0
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
###end article-title 0
###begin p 1
D.B. Rosen's present address is Nodality, Inc., South San Francisco, CA 94080.
###end p 1
###begin p 2
###xml 318 323 <span type="species:ncbi:9606">Human</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 807 812 <span type="species:ncbi:9606">human</span>
Plasmacytoid dendritic cells (pDCs) produce copious type I interferon (IFN) upon sensing nucleic acids through Toll-like receptor (TLR) 7 and TLR9. Uncontrolled pDC activation and IFN production are implicated in lymphopenia and autoimmune diseases; therefore, a mechanism controlling pDC IFN production is essential. Human pDCs specifically express an orphan receptor, immunoglobulin-like transcript 7 (ILT7). Here, we discovered an ILT7 ligand expressed by human cell lines and identified it as bone marrow stromal cell antigen 2 (BST2; CD317). BST2 directly binds to purified ILT7 protein, initiates signaling via the ILT7-FcϵRIgamma complex, and strongly inhibits production of IFN and proinflammatory cytokines by pDCs. Readily induced by IFN and other proinflammatory cytokines, BST2 may modulate the human pDC's IFN responses through ILT7 in a negative feedback fashion.
###end p 2
###begin p 3
###xml 224 246 224 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Jarrossay et al., 2001</xref>
###xml 248 269 248 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Kadowaki et al., 2001</xref>
###xml 271 280 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Liu, 2005</xref>
###xml 282 302 282 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Gilliet et al., 2008</xref>
###xml 480 500 480 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Colonna et al., 2004</xref>
###xml 502 527 502 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Honda and Taniguchi, 2006</xref>
###xml 529 550 529 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Kawai and Akira, 2006</xref>
###xml 552 573 552 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Piqueras et al., 2006</xref>
###xml 575 595 575 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Gilliet et al., 2008</xref>
###xml 742 760 742 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Novak et al., 2004</xref>
###xml 762 780 762 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Fuchs et al., 2005</xref>
###xml 782 803 782 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Blasius et al., 2006a</xref>
###xml 805 821 805 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 823 827 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">2007</xref>
###xml 829 846 829 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">R&#246;ck et al., 2007</xref>
###xml 848 864 848 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Cho et al., 2008</xref>
###xml 866 886 866 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Gilliet et al., 2008</xref>
###xml 1038 1056 1038 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 1017 1023 <span type="species:ncbi:9606">humans</span>
In humans and other mammals, plasmacytoid DCs (pDCs) are specialized immune cells that selectively express Toll-like receptor (TLR) 7 and TLR9, which are key endosomal sensors of microbial and self-RNA or DNA, respectively (Jarrossay et al., 2001; Kadowaki et al., 2001; Liu, 2005; Gilliet et al., 2008). Activation of TLR7 or TLR9 by nucleic acids in pDCs triggers signal transduction, leading to rapid and robust secretion of type I IFN, inflammatory cytokines, and chemokines (Colonna et al., 2004; Honda and Taniguchi, 2006; Kawai and Akira, 2006; Piqueras et al., 2006; Gilliet et al., 2008). The TLR-induced IFN response is regulated by several immunoreceptor tyrosine-based activation motif (ITAM)-bearing signaling receptors on pDCs (Novak et al., 2004; Fuchs et al., 2005; Blasius et al., 2006a; Cao et al., 2006, 2007; Rock et al., 2007; Cho et al., 2008; Gilliet et al., 2008). One such receptor is ILT7, a member of the Ig-like transcript (ILT) family (also known as leukocyte Ig-like receptors) found in humans and primates (Brown et al., 2004).
###end p 3
###begin p 4
###xml 281 299 281 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#1013;</italic>
###xml 693 709 689 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 711 727 707 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Cho et al., 2008</xref>
###xml 946 966 942 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Chapman et al., 1999</xref>
###xml 968 986 964 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 550 555 <span type="species:ncbi:9606">human</span>
ILTs, which are expressed by a variety of immune cell types, are comprised of a group of inhibitory receptors bearing immunoreceptor tyrosine-based inhibitory motifs and a group of stimulatory receptors that signal through their association with adaptor molecules containing ITAM (Brown et al., 2004). ILT7, also known as LILRA4 and CD85g, contains four extracellular Ig-like domains and a positively charged residue within the transmembrane region, allowing ILT7 to form a receptor complex with a signaling adaptor FcϵRIgamma. Uniquely expressed by human pDCs, ILT7 suppresses TLR7/9-induced type I IFN secretion by pDCs when cross-linked by anti-ILT7 mAbs that trigger signaling activation (Cao et al., 2006; Cho et al., 2008). Although several members of the inhibitory ILT family regulate innate and adaptive immune responses through interaction with classical and nonclassical MHC class I ligands or virus-encoded MHC class I-like proteins (Chapman et al., 1999; Brown et al., 2004), the natural ligands for the stimulatory ILTs, including ILT7, are unknown.
###end p 4
###begin p 5
###xml 228 233 <span type="species:ncbi:9606">human</span>
Here, we report the identification of a surface molecule named bone marrow stromal cell antigen 2 (BST2) as a biological ligand for ILT7 and provide evidence that BST2-ILT7 engagement may serve as a force to negatively regulate human pDCs' innate immune functions, likely during inflammation, in a negative feedback manner.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cancer cells express novel ILT7 ligand
###end title 7
###begin p 8
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#1013;</italic>
###xml 146 162 142 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 498 506 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 711 719 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
Previously, we constructed an NFAT-GFP reporter cell line expressing ILT7 and FcϵRIgamma that expresses GFP in response to ILT7 surface ligation (Cao et al., 2006). To detect the presence of ILT7 ligands (ILT7-L), we used these cells to screen virus-infected cells and a large panel of human tumor cell lines. Co-culture of the ILT7 reporter cells with human breast carcinoma MDA-MB-468, MCF7, and T47D cells, but not with MDA-MB-231 or ZR-75-1 cells, induced GFP expression by the reporter cells (Fig. 1 A). We further tested several human ovarian, colon, melanoma, glioma, and lung cancer cell lines and found that two melanoma lines, WM35 and Mel938, were able to similarly activate the ILT7 reporter cells (Fig. 1 B). Other transformed cell lines, such as HEK293, Vero, CHO, Cos7, and Jurkat, were unable to stimulate the ILT7 reporter cells (unpublished data).
###end p 8
###begin p 9
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Human tumor cell lines express a potential ligand for ILT7.</bold>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 319 324 <span type="species:ncbi:9606">Human</span>
Human tumor cell lines express a potential ligand for ILT7. (A) Five human breast cancer cell lines were co-cultured with either ILT7+ NFAT-GFP reporter cells or parental NFAT-GFP reporter cells. The percentages of GFP-positive reporter cells were analyzed. Data are representative of four independent experiments. (B) Human carcinoma cells were co-cultured with ILT7+ NFAT-GFP reporter cells. The percentages of GFP-positive reporter cells were analyzed. The categories of the cancer lines are as follows: OVCAR-3, SKOV-3, and DOV-13 (ovarian); HT-29 and HCT-116 (colon); WM35, WM239, MEL526, MEL624, MEL888, and MEL938 (melanoma); U87, LN229, and SNB19 (glioblastoma); A549 (lung cancer). Data are representative of two independent experiments. (C) T47D cells were co-cultured with ILT7+ NFAT-GFP reporter cells in the presence of 1 microg/ml of control IgG1 or anti-ILT7 mAb. The percentages of GFP-positive reporter cells were plotted. Data are representative of four independent experiments. (D) Breast cancer MDA-MB-468 cells were first cultured for 5 d in the presence of medium, 5 ng/ml of TNF-alpha or 500 U/ml of IFN-alpha, and then co-cultured with NFAT-GFP reporter cells. The percentages of GFP-positive reporter cells were analyzed. Data are representative of four independent experiments. Error bars represent the mean +/- the SEM.
###end p 9
###begin p 10
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#1013;</italic>
###xml 295 303 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 398 406 394 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 542 550 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
As the breast cancer line T47D is most potent in triggering ILT7, we further characterized these cells. The ability of T47D cells to activate the reporter cells is ILT7 dependent because NFAT-GFP reporter cells expressing only the signaling adaptor FcϵRIgamma, and not ILT7, were not activated (Fig. 1 A). In addition, the induction of GFP was completely abolished by a neutralizing anti-ILT7 mAb (Fig. 1 C). Pretreatment with IFN-alpha and TNF-alpha enhanced the ability of the breast cancer MDA-MB-468 cells to activate the ILT7 reporters (Fig. 1 D), suggesting that ILT7-L expression is regulated by immune responses.
###end p 10
###begin p 11
###xml 290 310 290 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Navarro et al., 1999</xref>
###xml 312 330 312 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 431 436 <span type="species:ncbi:9606">human</span>
ILT7 activation by cancer cells requires direct cell-cell contact as cells cultured in separate chambers of a transwell dish fail to induce GFP (unpublished data). Although the two other ILT family members, ILT2 and ILT4, bind to the classical and nonclassical MHC class I (MHC-I) ligands (Navarro et al., 1999; Brown et al., 2004), the putative ILT7-L appears to be unrelated to MHC class I or class II because antibodies against human MHC class I or class II did not block the ability of T47D cells to activate the ILT7 reporter cells (unpublished data), and both the MHC class I-expressing cell lines (e.g., Jurkat and MDA-MB-231) and the MHC class II-expressing cell lines (e.g., EBV-transformed B cells) were unable to activate ILT7 reporter cells (unpublished data).
###end p 11
###begin title 12
Identification of ILT7-L
###end title 12
###begin p 13
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
To facilitate the identification of the putative ILT7-L, we immunized mice with T47D (ILT7-Lpos) and MDA-MB-231 (ILT7-Lneg) cells and obtained multiple hybridoma clones that bound specifically to T47D cells, but not to MDA-MB-231 cells. To identify mAbs that specifically recognize ILT7-L, we further screened the hybridoma clones for the ability to block T47D-induced ILT7 reporter cell activation. Two such clones (26F8 and 28G4) were identified (Fig. 2 A).
###end p 13
###begin p 14
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Characterization of mAbs against a putative ILT7 ligand.</bold>
###xml 387 392 <span type="species:ncbi:9606">human</span>
Characterization of mAbs against a putative ILT7 ligand. (A) Culture supernatants from different hybridoma clones were included in the co-cultures of ILT7 reporter cells and T47D cells. The percentages of GFP-positive reporter cells were determined. Two clones able to inhibit GFP induction are indicated (arrows). Anti-ILT7 mAb (clone 17.2) was included as a positive control. (B) Five human breast cancer cells were stained with mAb 26F8 (red line) or an isotype-matched control mAb (shaded area) and analyzed by flow cytometry. A similar result obtained with mAb 28G4 is not shown. Data are representative of three independent experiments. (C) T47D cells were co-cultured with ILT7 reporter cells in the presence of control IgG1, 26F8, or 28G4 mAbs at different concentrations. The percentages of GFP-positive reporter cells were plotted. Data are representative of four independent experiments. (D) Surface biotinylated MDA-MB-231 and T47D were immunoprecipitated with control IgG1, 26F8, or 28G4. The precipitated proteins were analyzed by Western blotting with NeutrAvidin-HRP. Arrows indicate the specific protein bands obtained from T47D cells. Data are representative of two independent experiments.
###end p 14
###begin p 15
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 635 643 635 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 936 944 936 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
Using flow cytometry, we found that these two mAbs stained the breast tumor cell lines MDA-MB-468, MCF7, and T47D, which activated ILT7 reporter cells, but minimally reacted with breast tumor cell lines MDA-MB-231 and ZR-75-1, which failed to activate ILT7 reporters (Fig. 2 B). Other cell lines (e.g., HEK293, Vero, CHO, and Cos 7) that failed to activate the ILT7 reporter cells were not stained by either 26F8 or 28G4 (unpublished data). In addition, these two mAbs, but not the isotype-matched control mAb, strongly inhibited the ability of the tumor cell line T47D to activate the ILT7 reporter cells in a dose-dependent fashion (Fig. 2 C). The two mAbs recognize nonoverlapping epitopes, because one did not block the binding of the other to T47D cells, as determined by flow cytometry (unpublished data). Nevertheless, 26F8 and 28G4 mAbs immunoprecipitated three similar protein bands in T47D cells, but not in MDA-MB-231 cells (Fig. 2 D), suggesting the presence of cellular proteins as the potential ligand for ILT7.
###end p 15
###begin p 16
###xml 379 398 379 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Ohtomo et al., 1999</xref>
###xml 400 412 400 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Kupzig, 2003</xref>
###xml 414 442 414 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Walter-Yohrling et al., 2003</xref>
###xml 536 557 532 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Blasius et al., 2006b</xref>
###xml 559 576 555 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Neil et al., 2008</xref>
###xml 578 600 574 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Van Damme et al., 2008</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
To identify the ligand for ILT7, 26F8 and 28G4 mAbs were used to screen a human cDNA library. Both antibodies specifically recognized the gene product of human BST2 (CD317). BST2 is a 180-aa glycoprotein that was initially identified as a membrane protein expressed by bone marrow stromal cells and later shown to be expressed by plasma cells and multiple types of cancer cells (Ohtomo et al., 1999; Kupzig, 2003; Walter-Yohrling et al., 2003). BST2 is reportedly expressed on many different types of cells after exposure to IFN-alpha (Blasius et al., 2006b; Neil et al., 2008; Van Damme et al., 2008).
###end p 16
###begin title 17
BST2 is an ILT7 ligand
###end title 17
###begin p 18
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 400 402 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 520 528 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
The 26F8 and 28G4 mAbs stained the human BST2 cDNA-transfected HEK293 cells, but not mock-transfected cells, by flow cytometry (Fig. 3 A). In addition, recombinant ILT7 protein directly bound to a recombinant BST2-GST fusion protein, but not GST protein, in a dose-dependent manner (Fig. 3 B). Specific interaction between recombinant BST2-Fc and ILT7-Fc with an estimated affinity of approximately10-6 M was detected by surface plasma resonance with Biacore, an interaction that was completely neutralized by 26F8 mAb (Fig. 3 C).
###end p 18
###begin p 19
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2 directly binds to ILT7.</bold>
###xml 576 581 <span type="species:ncbi:9606">human</span>
BST2 directly binds to ILT7. (A) HEK293 cells transiently transfected with mock control or BST2 cDNA were analyzed by Western blotting for BST2 protein expression. Transfected cells were stained with 26F8 mAb and analyzed by flow cytometry. The staining profile with IgG isotype-matched control mAb is shown in the shaded area. Staining with 28G4 mAb produced identical results (not depicted). Data are representative of five independent experiments. (B) Plate-coated GST or BST2-GST were incubated with different concentrations of recombinant ILT7-Fc and HRP-conjugated anti-human Fc. Shown is absorption at OD 450 nm for each sample after addition of Tetramethyl benzidine (TMB) substrate. Data are representative of three independent experiments. (C, top) Recombinant BST2-Fc, precoated on the surface of Biacore sensor chips, was mixed with different concentrations of injected recombinant ILT7-Fc. The kinetic response data after subtracting the value from precoated Fc are shown. Also shown are control responses with Fc alone or buffer. (bottom) Precoated recombinant BST2-Fc was premixed with buffer, control IgG1, or anti-BST2 mAb 26F8 and then exposed to injected recombinant ILT7-Fc. The kinetic response data after subtracting the value from precoated Fc are shown. Data are representative of two independent experiments.
###end p 19
###begin p 20
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 692 700 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
Furthermore, rBST2-GST fusion protein, but not GST alone, strongly activated the ILT7 reporter cells (Fig. 4 A). The specificity of the BST2-ILT7 interaction was demonstrated by the findings that rBST2-GST failed to induce GFP expression in ILT7-negative reporter cells and that BST2-induced GFP expression in the ILT7 reporter cells was abrogated by neutralizing antibodies against either ILT7 or BST2, but not by control antibody. More importantly, BST2 expressed on the surface of HEK293 cells induced GFP expression in ILT7 reporter cells, but not in ILT7-negative reporter cells. Again, activation of the ILT7 reporter was blocked by neutralizing antibodies against either ILT7 or BST2 (Fig. 4 B). These data identify BST2 as a physiological ligand that specifically binds and activates ILT7.
###end p 20
###begin p 21
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2 binds and potently activates ILT7.</bold>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 478 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 527 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
BST2 binds and potently activates ILT7. (A) GST or BST2-GST protein was co-cultured with ILT7+ NFAT-GFP reporter cells. The percentages of GFP-positive reporter cells are shown. Neutralizing antibodies alphaILT7 (5 microg/ml) or 26F8 (25 microg/ml) or an IgG1 control antibody were included in the cultures, as indicated. Data are representative of four independent experiments. (B) HEK293 cells transiently transfected with mock control or BST2 cDNA were co-cultured with ILT7+ NFAT-GFP reporter cells. The percentages of GFP+ reporter cells are shown. Neutralizing antibodies alphaILT7 (5 microg/ml), 26F8 (25 microg/ml), 28G4 (25 microg/ml), or control IgG1 were included in the cultures, as indicated. Data are representative of three independent experiments.
###end p 21
###begin title 22
###xml 57 62 <span type="species:ncbi:9606">human</span>
BST2 negatively regulates the innate immune functions of human pDCs
###end title 22
###begin p 23
###xml 155 171 151 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 173 189 169 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Cho et al., 2008</xref>
###xml 341 349 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 291 296 <span type="species:ncbi:9606">human</span>
As previously shown, antibody cross-linking of ILT7 can induce prominent calcium influx in primary pDCs as a result of ITAM-mediated FcϵRIgamma signaling (Cao et al., 2006; Cho et al., 2008). Similarly, a rBST2-Fc protein, but not a control Fc protein alone, induced calcium mobilization in human pDCs, which depends on the function of Syk (Fig. 5 A).
###end p 23
###begin p 24
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BST2 activates primary pDCs and inhibits IFN and cytokine production by pDCs.</bold>
BST2 activates primary pDCs and inhibits IFN and cytokine production by pDCs. (A) pDCs were incubated with anti-ILT7, recombinant Fc, or BST2-Fc proteins and then analyzed for calcium influx. pDCs pretreated with 5 microM of Syk inhibitor were also analyzed. Data are representative of three independent experiments. (B) The amounts of secreted cytokines from pDCs cultured with plate-bound Fc or BST2-Fc are shown. pDCs were activated overnight with either 0.2 microM of CpG 2216 or MOI 6 of Flu. Data are representative of five independent experiments with ten donors. (C) The levels of gene transcripts from pDCs cultured with purified Fc or BST2-Fc are shown. The relative expression of each gene was normalized with S18 and calculated against the value obtained from normal total PBMCs. Data are representative of two independent experiments. (D) BST2 does not affect co-stimulatory molecule expression by pDCs. pDCs cultured with plate-bound Fc or BST2-Fc and then activated with 0.2 microM of CpG 2216 for 48 h. Surface levels of CD80 and CD86 are shown. Data are representative of two independent experiments. (E) pDCs preincubated with medium, 20 microg/ml of IgG1 or 20 microg/ml of neutralizing ILT7 mAb were cultured overnight with plate-bound Fc or BST2-Fc in the presence of CpG 2216. The amounts of secreted IFN-alpha were measured by ELISA. Percent of BST2-mediated IFN-alpha suppression was calculated as percent ratio of IFN-alpha ([Fc minus BST2-Fc]/[Fc]) and plotted. Data are representative of two independent experiments with four donors. (F) The amounts of secreted IFN-alpha from Flu-challenged pDCs cultured with HEK293 with or without surface HA-tagged BST2 are shown. Data are representative of two independent experiments.
###end p 24
###begin p 25
###xml 460 468 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 601 609 578 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 747 762 724 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, C and D</xref>
###xml 951 959 928 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 E</xref>
###xml 1164 1172 1137 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 F</xref>
###xml 177 182 <span type="species:ncbi:9606">human</span>
Because mAb cross-linking of ILT7 inhibits the immune response of pDCs, we investigated the effect of BST2 on TLR-induced cytokine responses by pDCs. Freshly isolated pDCs from human peripheral blood were preincubated with plate-bound rBST2-Fc protein or plate-bound Fc protein for 30 min, and were then challenged with influenza virus (Flu) or CpG, which trigger TLR7 and TLR9, respectively. rBST2 protein suppressed the secretion of IFN-alpha and TNF-alpha (Fig. 5 B), as well as the transcription of type I IFN subtypes, including IFNalpha1, IFNalpha4, IFNalpha8, and IFN-beta, plus IL-6, by pDCs (Fig. 5 C) when activated by TLR agonists. In contrast, BST2 did not alter expression of co-stimulatory molecules, such as CD80 and CD86, by pDCs (Fig. 5, C and D). The effect of BST2-mediated IFN suppression was abolished when ILT7 was neutralized with anti-ILT7 mAb, but not with control IgG1, indicating a direct engagement between ILT7 and rBST2 (Fig. 5 E). Lastly, pDCs co-cultured with HEK293 cells expressing an HA-tagged BST2 secreted reduced levels of IFN-alpha in response to Flu virus when compared with pDCs in contact with untransfected HEK293 cells (Fig. 5 F), suggesting that the BST2-ILT7 interaction modulates pDCs' TLR-induced IFN responses.
###end p 25
###begin title 26
###xml 19 24 <span type="species:ncbi:9606">human</span>
BST2 expression by human cells and by pDCs
###end title 26
###begin p 27
###xml 358 366 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 589 610 581 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Blasius et al., 2006b</xref>
###xml 612 629 604 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Neil et al., 2008</xref>
###xml 631 653 623 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Van Damme et al., 2008</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
To understand the prevalence of BST2 expression on human cells in response to IFN treatment, we cultured embryonic kidney HEK293 cells, dermal fibroblast line NHDF cells, human umbilical vein endothelial line HUVEC cells, and keratinocyte line HaCat cells in the absence or presence of IFN-alpha, and then analyzed BST2 surface expression by flow cytometry (Fig. 6 A). Although these cells minimally express BST2 under normal conditions, IFN-alpha treatment resulted in significant surface BST2 expression in all of them, which is consistent with the reported IFN-mediated BST2 induction (Blasius et al., 2006b; Neil et al., 2008; Van Damme et al., 2008).
###end p 27
###begin p 28
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Analysis of BST2 expression and potential BST2&#8211;ILT7 cis-interaction.</bold>
###xml 573 578 <span type="species:ncbi:9606">Human</span>
Analysis of BST2 expression and potential BST2-ILT7 cis-interaction. (A) HEK293, NHDF, HUVEC, and HaCat cells, cultured in the absence or presence of 500 units/ml of IFN-alpha for 48 h, were stained with anti-BST2 mAb 26F8. Staining with isotype-matched control Ig is shown in the gray shaded area. Data are representative of three independent experiments. (B) Fresh isolated pDCs from peripheral blood or cells activated with various stimuli for 48 h were analyzed for surface BST2 expression by flow cytometry. Data are representative of two independent experiments. (C) Human Burkitt's lymphoma Namalwa cells transduced with different pDC receptor complexes, i.e., BDCA2/FcϵRIgamma or ILT7/FcϵRIgamma, were analyzed for surface BST2 and ILT7 expression. Data are representative of three independent experiments.
###end p 28
###begin p 29
###xml 60 81 60 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Blasius et al., 2006b</xref>
###xml 140 158 140 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 737 745 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 664 669 <span type="species:ncbi:9606">human</span>
###xml 861 866 <span type="species:ncbi:9606">human</span>
Interestingly, resting mouse pDCs prominently express BST2 (Blasius et al., 2006b), but lack the expression of a direct orthologue of ILT7 (Brown et al., 2004). However, low amounts of surface BST2 were detected on human pDCs that were freshly isolated or cultured with either TLR ligands or cytokines (Fig. 6 B), although BST2 transcripts were found elevated in TLR-activated pDCs (unpublished data). To investigate a potential cis interaction between ILT7 and BST2, we transduced ILT7 and FcϵRIgamma into a human Burkitt's lymphoma cell line expressing endogenous BST2. Interestingly, expression of the ILT7-FcϵRIgamma complex, but not BDCA2-FcϵRIgamma, another human pDC-specific receptor complex, reduced the levels of surface BST2 (Fig. 6 C). Thus, ILT7-BST2 cis interaction likely results in BST2 internalization and might have functional consequences in human pDCs.
###end p 29
###begin title 30
DISCUSSION
###end title 30
###begin p 31
###xml 380 396 373 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Lin et al., 1998</xref>
###xml 398 419 391 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Kamphuis et al., 2006</xref>
###xml 461 485 454 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Gota and Calabrese, 2003</xref>
###xml 822 841 815 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Ohtomo et al., 1999</xref>
###xml 843 864 836 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Blasius et al., 2006b</xref>
###xml 866 883 859 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Neil et al., 2008</xref>
###xml 885 907 878 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Van Damme et al., 2008</xref>
###xml 1069 1075 1062 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Here, we identify BST2 as a physiological ligand for a human pDC-specific receptor ILT7. pDCs play a critical role in antiviral innate immune responses by secreting large quantities of IFN-alpha/beta. However, the type 1 IFN responses immediately after viral infection are short lived; if not, massive and prolonged IFN exposure will damage hematopoiesis, leading to lymphopenia (Lin et al., 1998; Kamphuis et al., 2006), and increase the risk of autoimmunity (Gota and Calabrese, 2003). Hence, a mechanism ensuring a specific and transient IFN response to viruses is critical to minimize the possibility of lymphopenia and autoimmune diseases in the host. As BST2 is well known to be robustly induced on the surface of various types of cells after exposure to IFN and other proinflammatory cytokines via STAT activation (Ohtomo et al., 1999; Blasius et al., 2006b; Neil et al., 2008; Van Damme et al., 2008), the BST2-ILT7 interaction, therefore, likely serves as an important negative feedback mechanism for preventing prolonged IFN production after viral infection (Fig. 7).
###end p 31
###begin p 32
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A proposed model of BST2&#8211;ILT7 mediated regulation of pDC innate immune responses.</bold>
A proposed model of BST2-ILT7 mediated regulation of pDC innate immune responses. (top) By sensing viral infection, pDCs can rapidly and rigorously produce large amounts of IFN-I via TLR7 or TLR9 activation. IFN-I then may induce the neighboring cells to express BST2, which in turn engages with ILT7 on pDCs to down-regulate the magnitude of IFN and cytokine responses in a negative feedback manner. (bottom) In a tumor environment where BST2 is endogenously expressed, infiltrating pDCs may be functionally suppressed to elicit normal IFN response to TLR ligands as a result of BST2-ILT7 interaction.
###end p 32
###begin p 33
###xml 91 108 91 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Haas et al., 2008</xref>
###xml 372 390 372 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Lande et al., 2007</xref>
###xml 392 426 392 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Marshak-Rothstein and Rifkin, 2007</xref>
###xml 428 445 428 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">Tian et al., 2007</xref>
###xml 571 591 567 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Vollmer et al., 2005</xref>
###xml 593 614 589 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Savarese et al., 2006</xref>
###xml 927 946 923 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Blanco et al., 2001</xref>
###xml 948 966 944 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Lande et al., 2007</xref>
###xml 968 1002 964 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Marshak-Rothstein and Rifkin, 2007</xref>
###xml 869 877 <span type="species:ncbi:9606">patients</span>
Intracellular TLRs have limited ability to discriminate host versus foreign nucleic acids (Haas et al., 2008). Several host factors, including anti-DNA antibodies, antimicrobial peptide LL37, or the nuclear DNA-binding protein HMGB1, alone or in combination, facilitate entry of self-DNA into the endosomes of pDCs, where they trigger TLR9 to induce type 1 IFN responses (Lande et al., 2007; Marshak-Rothstein and Rifkin, 2007; Tian et al., 2007). Similarly, autoantibody-self small nuclear ribonucleoprotein complexes can activate TLR7 through FcgammaRII to induce IFN (Vollmer et al., 2005; Savarese et al., 2006). This might lead to the constitutive activation of pDCs, which contributes to the autoimmune pathology of systemic lupus erythematosus and psoriasis. It will be of further interest to study if the BST2-ILT7-mediated controlling mechanism is breached in patients with systemic lupus erythematosus and psoriasis (Blanco et al., 2001; Lande et al., 2007; Marshak-Rothstein and Rifkin, 2007), which may provide an opportunity to develop therapeutics to down-modulate pDC activation during autoimmune disease.
###end p 33
###begin p 34
###xml 110 128 110 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 550 570 550 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Chapman et al., 1999</xref>
###xml 649 668 649 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Cosman et al., 1997</xref>
###xml 670 688 670 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Brown et al., 2004</xref>
###xml 818 840 818 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Shiroishi et al., 2006</xref>
###xml 1308 1320 1308 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Kupzig, 2003</xref>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 527 548 <span type="species:ncbi:10359">human cytomegalovirus</span>
Interestingly, BST2 represents the first non-MHC class I-type ligand for a member of the ILT receptor family (Brown et al., 2004). By sequence analysis, human receptor ILTs are divided into two separate groups-five inhibitory ILTs containing intracellular immunoreceptor tyrosine-based inhibitory motifs and six stimulatory ILTs that would couple with ITAM-bearing adaptors. The inhibitory ILTs, e.g., ILT2 and ILT4, recognize proteins encoded by many MHC class I alleles and UL18, which is a MHC-like molecule associated with human cytomegalovirus (Chapman et al., 1999). However, the ligands for the stimulatory group of ILTs are largely unknown (Cosman et al., 1997; Brown et al., 2004). Structural analysis revealed significant differences in MHC class I-binding sites between the inhibitory and stimulatory ILTs (Shiroishi et al., 2006), suggesting distinct ligand recognition by the two groups of ILTs. Here, we used a NFAT-GFP reporter cell system that reliably senses ILT7 surface ligation in the presence of an ILT7 ligand, which led to the positive identification of BST2, a glycoprotein unrelated to the MHC molecules. BST2 protein has a unique topology, containing an N-terminal transmembrane domain and a C-terminal GPI anchor, and locates within the lipid raft microdomains on plasma membrane (Kupzig, 2003). Further structural analysis of the binding interface between BST2 and ILT7 may shed light on the structural basis of ligand recognition by ILT7 and stimulatory ILTs. The receptor-NFAT reporter system should be also useful for the identification of the relevant ligands for other ILT orphan receptors and a better understanding of ILT's biological function.
###end p 34
###begin p 35
###xml 352 364 352 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Lanier, 2008</xref>
###xml 366 390 366 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib66">Yamada and McVicar, 2008</xref>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 523 545 523 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Karlhofer et al., 1992</xref>
###xml 647 665 647 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Arase et al., 2002</xref>
###xml 667 685 667 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">Smith et al., 2002</xref>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 764 787 764 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Desrosiers et al., 2005</xref>
###xml 906 927 902 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Cerwenka et al., 2000</xref>
###xml 929 952 925 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Diefenbach et al., 2001</xref>
###xml 954 958 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">2003</xref>
###xml 960 988 956 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Carayannopoulos et al., 2002</xref>
###xml 1077 1096 1073 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Lodoen et al., 2003</xref>
###xml 1098 1119 1094 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Hamerman et al., 2004</xref>
###xml 1121 1138 1117 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Nice et al., 2009</xref>
###xml 1212 1230 1208 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Bauer et al., 1999</xref>
###xml 1272 1291 1268 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Cosman et al., 2001</xref>
###xml 1293 1314 1289 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Chalupny et al., 2003</xref>
###xml 1390 1410 1386 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Ebihara et al., 2007</xref>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 726 731 <span type="species:ncbi:10090">mouse</span>
###xml 1144 1149 <span type="species:ncbi:9606">human</span>
As the innate immune system has widely adopted "paired receptors" to exert tight regulatory control, many of the inhibitory receptors participate in self tolerance by recognizing ubiquitously expressed endogenous molecules, whereas stimulatory receptors may recognize "alert" molecules that are up-regulated after viral infection or immune activation (Lanier, 2008; Yamada and McVicar, 2008). For example, Ly49A, a prototype inhibitory Ly49 receptor expressed on mouse NK cells, recognizes endogenous MHC-I molecule H-2Dd (Karlhofer et al., 1992), whereas stimulatory NK receptor Ly49H binds to glycoprotein M157 encoded by mouse cytomegalovirus (Arase et al., 2002; Smith et al., 2002), Ly49P recognizes the H-2Dk-restricted mouse cytomegalovirus-infected cells (Desrosiers et al., 2005), and NKG2D interacts with ligands with structural homology with MHC class I, including RAE-1alpha-ϵ, H60, and MULT1 (Cerwenka et al., 2000; Diefenbach et al., 2001, 2003; Carayannopoulos et al., 2002), expression of which is under control of TLR activation, viral infections, and stress (Lodoen et al., 2003; Hamerman et al., 2004; Nice et al., 2009). In human, NKG2D engages with MHC class I-like molecules MICA and MICB (Bauer et al., 1999), inducible by cell stress, and ULBP1-4 (Cosman et al., 2001; Chalupny et al., 2003), expression of which is influenced by TLR activation or viral infections (Ebihara et al., 2007). The fact that BST2 is a gene product whose expression is under control of inflammatory signals is consistent with the notion that stimulatory receptors may regulate immune functions by interacting with inducible or pathogen-associated ligands.
###end p 35
###begin p 36
###xml 279 299 279 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Dzionek et al., 2001</xref>
###xml 301 319 301 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Novak et al., 2004</xref>
###xml 321 339 321 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Fuchs et al., 2005</xref>
###xml 341 357 341 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">2007</xref>
###xml 519 540 519 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Blasius et al., 2006a</xref>
###xml 699 715 699 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Tai et al., 2008</xref>
###xml 81 86 <span type="species:ncbi:9606">Human</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 610 615 <span type="species:ncbi:10090">mouse</span>
Like NK cells, pDCs express both inhibitory receptors and stimulatory receptors. Human pDC receptors ILT7, BDCA2, high-affinity Fc receptor for IgE, and NKp44, which all signal through an ITAM-mediated pathway, exert negative effects on the pDC's IFN response to TLR activation (Dzionek et al., 2001; Novak et al., 2004; Fuchs et al., 2005; Cao et al., 2006, 2007). Similarly, activation of Siglec-H, in association with the ITAM-bearing DAP12 subunit, reduces type I IFN production by mouse pDCs in vitro and in vivo (Blasius et al., 2006a). On the other hand, Ly49Q, an inhibitory Ly49 receptor expressed on mouse pDCs, recognizes MHC class I molecules and enhances pDC's innate immune responses (Tai et al., 2008). Thus, it appears that the so-called stimulatory receptors may exercise potent suppressive regulatory functions on the innate immunity of pDCs.
###end p 36
###begin p 37
###xml 94 110 94 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">Zou et al., 2001</xref>
###xml 112 128 112 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Wei et al., 2005</xref>
###xml 146 168 146 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">Treilleux et al., 2004</xref>
###xml 181 199 181 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Salio et al., 2003</xref>
###xml 201 227 201 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Benitez-Ribas et al., 2006</xref>
###xml 240 258 240 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Mohty et al., 2001</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">2004</xref>
###xml 285 309 285 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Della Bella et al., 2006</xref>
###xml 355 376 355 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Hartmann et al., 2003</xref>
###xml 514 536 514 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">Treilleux et al., 2004</xref>
###xml 625 645 625 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Sisirak et al., 2008</xref>
###xml 739 758 735 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib69">Wenzel et al., 2005</xref>
###xml 760 777 756 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Dunn et al., 2006</xref>
###xml 876 882 872 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 989 1009 981 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Matsuda et al., 2003</xref>
###xml 1100 1119 1092 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Ohtomo et al., 1999</xref>
###xml 1121 1133 1113 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Kupzig, 2003</xref>
###xml 1135 1163 1127 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Walter-Yohrling et al., 2003</xref>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Immature pDCs have been found in the local tumor environment of patients with ovarian cancer (Zou et al., 2001; Wei et al., 2005), breast cancer (Treilleux et al., 2004), melanoma (Salio et al., 2003; Benitez-Ribas et al., 2006), leukemia (Mohty et al., 2001, 2004), Kaposi's sarcoma (Della Bella et al., 2006), and head and neck squamous cell carcinoma (Hartmann et al., 2003). Although pDCs only infiltrate 13% of primary breast tumors, their presence strongly correlates with an adverse outcome of the disease (Treilleux et al., 2004). The breast cancer microenvironment profoundly inhibits pDC's innate immune functions (Sisirak et al., 2008). Because IFN-alpha is well known to be required for deterring the growth of primary tumors (Wenzel et al., 2005; Dunn et al., 2006), BST2-ILT7 interactions that suppress pDCs' IFN responses may contribute to the tumor tolerance (Fig. 7). On the other hand, BST2 found in multiple cancer types was identified as a potent inducer of NF-kappaB (Matsuda et al., 2003) and one of the candidate genes expressed in malignant cells that promote tumor invasion (Ohtomo et al., 1999; Kupzig, 2003; Walter-Yohrling et al., 2003). Thus, BST2-ILT7 interaction might be bidirectional in a cancer environment, and the consequence of ILT7 engagement on BST2-expressing tumor cells should be investigated in the future.
###end p 37
###begin title 38
MATERIALS AND METHODS
###end title 38
###begin title 39

###end title 39
###begin title 40
Reagents and cells.
###end title 40
###begin p 41
###xml 181 197 177 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 698 714 694 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Cao et al., 2007</xref>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 717 722 <span type="species:ncbi:9606">Human</span>
HEK293 cells were grown in high-glucose DME supplemented with 10% FBS, 50 U/ml penicillin, and 50 microg/ml streptomycin. Breast cancer cells and mouse 2B4 NFAT-GFP reporter cells (Cao et al., 2006) were grown in RPMI 1640 medium supplemented with 10% FBS and antibiotics. NHDF and HUVEC cells (Lonza) were cultured in Clonetics Fibroblast Cell Medium FGM-2 and Endothelial Cell Basal medium, respectively, supplemented with growth factors following the manufacturer's recommendations. HaCaT cells were provided by S. Ullrich (M.D. Anderson Cancer Center, Houston, TX) and cultured in RPMI 1640 medium supplemented with 10% FBS and antibiotics. Namalwa cells were cultured as previously described (Cao et al., 2007). Human TNF-alpha was purchased from Peprotech. IFN-alpha was purchased from Sigma-Aldrich.
###end p 41
###begin title 42
ILT7 reporter cell assay.
###end title 42
###begin p 43
###xml 98 99 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 317 318 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
ELISA plates were coated with 10 microg/ml of protein in PBS or at the concentration specified. 105 cancer cells or transfected HEK293 cells were seeded in 24-well plates the day before the experiment. After 105 NFAT-GFP reporter cells were added to the ELISA plate or the cell monolayer, the plates were spun at 100 g for 2 min. After overnight culture, cells were subjected to flow cytometric analysis to measure GFP expression.
###end p 43
###begin title 44
###xml 19 24 <span type="species:ncbi:9606">human</span>
BST2 activation of human primary pDCs.
###end title 44
###begin p 45
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 433 434 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 831 847 823 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 951 967 939 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 1391 1392 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1511 1512 1495 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1744 1745 1728 1729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1866 1882 1850 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 435 439 <span type="species:ncbi:9925">goat</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 1720 1724 <span type="species:ncbi:9925">goat</span>
###xml 1730 1735 <span type="species:ncbi:9606">human</span>
The institutional review board for human research at the M.D. Anderson Cancer Center approved the use of human blood samples for this study. Primary human pDCs were isolated from blood using a negative selection kit (Miltenyi Biotech) and sorted by flow cytometry as CD3-CD11c-CD14-CD15-CD16-CD19-CD56-CD4+CD123+ cells. pDCs were preincubated with plate-bound control Fc protein or BST2-Fc protein captured with 10 microg/ml of F(ab)2 goat anti-human IgG Fc (Jackson ImmunoResearch Laboratories) on an ELISA plate for 30 min before stimulation with 0.2 microM of CpG 2216 (Sigma-Genosys) or heat-inactivated influenza virus PR8 at a multiplicity of infection (MOI) of 6. 18 h later, the supernatants were harvested and analyzed for cytokines, and the cells were lysed and RNA subjected to RT-PCR analysis, as previously described (Cao et al., 2006). To neutralize ILT7 in this assay, pDCs were preincubated with 20 microg/ml of anti-ILT7 (clone 17.2; Cao et al., 2006), washed, and then incubated with plate-bound Fc or BST2-Fc and stimulated with CpG. In parallel, control pDCs were preincubated with medium or 20 microg/ml of IgG1, washed, and stimulated similarly on Fc- or BST2-Fc-coated plates. To perform pDC and BST2-transfectant cell co-culture, pDCs were preincubated with inactivated influenza virus (MOI = 8) for 30 min, and cells were pelleted by centrifugation for 5 min at 500 g and added to parent HEK293 or BST2-HA-transfected HEK293 monolayers. Cells were packed briefly by centrifuging at 100 g for 2 min. 18 h later, the supernatants were harvested and analyzed for cytokine secretion. To study calcium influx, purified control Fc protein or BST2-Fc protein was incubated with pDCs in the presence of goat anti-human Fc F(ab)2 (Jackson ImmunoResearch Laboratories). Dye loading and flow cytometric analysis were performed as previously described (Cao et al., 2006).
###end p 45
###begin title 46
Anti-ILT7-L mAb generation.
###end title 46
###begin p 47
###xml 102 118 102 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cao et al., 2006</xref>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
6-8-wk-old BALB/c mice were immunized with T47D and MDA-MB-231 cells by the alternate footpad method (Cao et al., 2006). Hybridoma clones secreting mAbs that specifically stained T47D cells, but not MDA-MB-231 cells, were expanded. They were further screened for their ability to block T47D-induced GFP expression from ILT7+ reporter cells. mAbs 26F8 (IgG1) and 28G4 (IgG2a) were affinity purified and fluorochrome conjugated using mAb conjugation kits (Invitrogen).
###end p 47
###begin title 48
cDNA library screening.
###end title 48
###begin p 49
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 487 488 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 599 603 <span type="species:ncbi:9925">goat</span>
A library of human full-length cDNA clones was purchased from OriGene Technologies, Inc. Plasmid DNA was prepared using the Wizard plus miniprep kit (Promega). For transfection, HEK293 cells were seeded at 104 cells/well in 96-well plates. 0.6 microl of Fugene 6 (Roche) was added to 15 microl of Opti-MEM (Invitrogen) and mixed with 10 microl of DNA from individual cDNA clone. After 15 min at room temperature, the mixture was added to cells. 48 h later, cells were centrifuged at 200 g for 3 min before the media was removed. 5 microg/ml of mAbs 26F8 or 28G4 was added and mixed with Cy5-labeled goat anti-mIgG (Jackson ImmunoResearch Laboratories). Cells were incubated at room temperature for 2 h in the dark and analyzed by using a fluorometric microvolume assay technology 8100 HTS system (Applied Biosystems).
###end p 49
###begin title 50
BST2 transfection and expression analysis.
###end title 50
###begin p 51
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 235 241 <span type="species:ncbi:9986">rabbit</span>
HEK293 cells were transfected with an expression plasmid containing the full-length human BST2 cDNA (Open Biosystems) with lipofectamine (Invitrogen). 48 h later, cells were either lysed for Western blot analysis using a BST2-specific rabbit polyclonal antibody (FabGennix, Inc.) or subjected to staining with fluorochrome-conjugated anti-ILT7-L mAbs. HEK293 cells stably expressing BST2-HA were transfected with pcDNA3-zeo-BST2-HA, selected with Zeocin, and sorted for high HA expression by flow cytometry.
###end p 51
###begin title 52
Generation of recombinant ILT7 and BST2 fusion protein.
###end title 52
###begin p 53
###xml 166 184 166 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Arase et al., 2002</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
The extracellular domain of ILT7 or extracellular domain of BST2 (excluding GPI anchor) were cloned into an expression vector containing a mutated human Fc fragment (Arase et al., 2002). HEK293 cells were transiently transfected with the expression plasmids or the empty vector to produce recombinant protein, which was purified by using a Protein A column (GE Healthcare). The extracellular domain of BST2 (excluding GPI anchor) was constructed as a GST-fusion protein, which was stably expressed in CHOK1SV cells and purified by glutathione-Sepharose affinity chromatography (GE Healthcare).
###end p 53
###begin title 54
Surface plasma resonance analysis.
###end title 54
###begin p 55
Surface plasma resonance was performed using a Biacore 3000 (GE Healthcare). BST2-Fc and Fc were covalently immobilized onto flow cells of a CM5 sensor chip by amine coupling according to the manufacturer's instruction. ILT7-Fc, Fc, and 26F8 in 10 mM Hepes (pH 7.4), 150 mM NaCl, and 0.005% P20 were passed over the chip at 20 microl/min. To block the interactions between BST2 and ILT7, 26F8 (120 microg/ml), IgG1 (120 microg/ml), or buffer was injected over BST2-Fc-coated sensor chip before injection of ILT7-Fc (120 microg/ml).
###end p 55
###begin p 56
We thank David Son and Ran Zhang for excellent technical assistance and Dr. Margaret Kripke for critiques of the manuscript.
###end p 56
###begin p 57
This work is supported by grants from the National Institutes of Health (AI068129 to L.L. Lanier, AI074809 to W. Cao, and AI 059718 to Y.-J. Liu). L.L. Lanier is an American Cancer Society Research Professor.
###end p 57
###begin p 58
The authors have no conflicting financial interests.
###end p 58
###begin article-title 59
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.
###end article-title 59
###begin article-title 60
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
###end article-title 60
###begin article-title 61
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcgammaRII-mediated uptake.
###end article-title 61
###begin article-title 62
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
###end article-title 62
###begin article-title 63
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
###end article-title 63
###begin article-title 64
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation.
###end article-title 64
###begin article-title 65
The LILR family: modulators of innate and adaptive immune pathways in health and disease.
###end article-title 65
###begin article-title 66
Plasmacytoid dendritic cell-specific receptor ILT7-FcϵRIgamma inhibits Toll-like receptor-induced interferon production.
###end article-title 66
###begin article-title 67
###xml 69 74 <span type="species:ncbi:9606">human</span>
BDCA2/FcϵRIgamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells.
###end article-title 67
###begin article-title 68
###xml 14 20 <span type="species:ncbi:10090">murine</span>
###xml 126 132 <span type="species:ncbi:10090">murine</span>
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
###end article-title 68
###begin article-title 69
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.
###end article-title 69
###begin article-title 70
The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.
###end article-title 70
###begin article-title 71
###xml 28 33 <span type="species:ncbi:9606">human</span>
ULBP4 is a novel ligand for human NKG2D.
###end article-title 71
###begin article-title 72
SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production.
###end article-title 72
###begin article-title 73
Plasmacytoid dendritic cells in immunity.
###end article-title 73
###begin article-title 74
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
###end article-title 74
###begin article-title 75
###xml 52 55 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
ULBPs, novel MHC class I related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
###end article-title 75
###begin article-title 76
Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma.
###end article-title 76
###begin article-title 77
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection.
###end article-title 77
###begin article-title 78
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
###end article-title 78
###begin article-title 79
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
###end article-title 79
###begin article-title 80
Interferons, immunity and cancer immunoediting.
###end article-title 80
###begin article-title 81
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.
###end article-title 81
###begin article-title 82
###xml 30 35 <span type="species:ncbi:9606">human</span>
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection.
###end article-title 82
###begin article-title 83
###xml 24 29 <span type="species:ncbi:9606">human</span>
Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44.
###end article-title 83
###begin article-title 84
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.
###end article-title 84
###begin article-title 85
Induction of clinical autoimmune disease by therapeutic interferon-alpha.
###end article-title 85
###begin article-title 86
The DNA sugar backbone 2' deoxyribose determines Toll-like receptor 9 activation.
###end article-title 86
###begin article-title 87
Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor.
###end article-title 87
###begin article-title 88
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
###end article-title 88
###begin article-title 89
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
###end article-title 89
###begin article-title 90
###xml 72 77 <span type="species:ncbi:9606">human</span>
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.
###end article-title 90
###begin article-title 91
###xml 11 16 <span type="species:ncbi:9606">human</span>
Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens.
###end article-title 91
###begin article-title 92
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.
###end article-title 92
###begin article-title 93
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
###end article-title 93
###begin article-title 94
Innate immune recognition of viral infection.
###end article-title 94
###begin article-title 95
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology.
###end article-title 95
###begin article-title 96
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.
###end article-title 96
###begin article-title 97
Up on the tightrope: natural killer cell activation and inhibition.
###end article-title 97
###begin article-title 98
Impairment of T and B cell development by treatment with a type I interferon.
###end article-title 98
###begin article-title 99
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.
###end article-title 99
###begin article-title 100
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
###end article-title 100
###begin article-title 101
Immunologically active autoantigens: the role of Toll-Like receptors in the development of chronic inflammatory Disease.
###end article-title 101
###begin article-title 102
###xml 51 56 <span type="species:ncbi:9606">human</span>
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.
###end article-title 102
###begin article-title 103
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment.
###end article-title 103
###begin article-title 104
Plasmacytoid DCs and cancer: a new role for an enigmatic cell.
###end article-title 104
###begin article-title 105
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
###end article-title 105
###begin article-title 106
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
###end article-title 106
###begin article-title 107
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
###end article-title 107
###begin article-title 108
Characterization of FcϵRI-bearing CD123+ blood dendritic cell antigen-2+ plasmacytoid dendritic cells in atopic dermatitis.
###end article-title 108
###begin article-title 109
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.
###end article-title 109
###begin article-title 110
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors.
###end article-title 110
###begin article-title 111
CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2.
###end article-title 111
###begin article-title 112
Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
###end article-title 112
###begin article-title 113
U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.
###end article-title 113
###begin article-title 114
###xml 25 30 <span type="species:ncbi:9606">Human</span>
Crystal Structure of the Human Monocyte-activating Receptor, "Group 2" Leukocyte Ig-like Receptor A5 (LILRA5/LIR9/ILT11).
###end article-title 114
###begin article-title 115
###xml 34 39 <span type="species:ncbi:9606">human</span>
Breast tumor environment inhibits human plasmacytoid dendritic cells functions. 
###end article-title 115
###begin article-title 116
Recognition of a virus-encoded ligand by a natural killer cell activation receptor.
###end article-title 116
###begin article-title 117
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC.
###end article-title 117
###begin article-title 118
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
###end article-title 118
###begin article-title 119
Dendritic cell infiltration and prognosis of early stage breast cancer.
###end article-title 119
###begin article-title 120
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Interferon-Induced Protein BST-2 Restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
###end article-title 120
###begin article-title 121
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.
###end article-title 121
###begin article-title 122
Identification of genes expressed in malignant cells that promote invasion.
###end article-title 122
###begin article-title 123
###xml 63 68 <span type="species:ncbi:9606">human</span>
Plasmacytoid dendritic cells induce CD8+ regulatory t cells in human ovarian carcinoma.
###end article-title 123
###begin article-title 124
Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions.
###end article-title 124
###begin article-title 125
Paired receptor systems of the innate immune system.
###end article-title 125
###begin article-title 126
###xml 28 33 <span type="species:ncbi:9606">human</span>
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.
###end article-title 126
###begin p 127
Abbreviations used: BST2, bone marrow stromal cell antigen 2; ILT, Ig-like transcript; ITAM, immunoreceptor tyrosine-based activation motif; MOI, multiplicity of infection; pDC, plasmacytoid DC; TLR, Toll-like receptor.
###end p 127

